Anpario plc (LON:ANP) Insider Richard Edwards Purchases 25,000 Shares of Stock

Anpario plc (LON:ANPGet Rating) insider Richard Edwards acquired 25,000 shares of the business’s stock in a transaction on Thursday, April 6th. The shares were bought at an average cost of GBX 203 ($2.51) per share, for a total transaction of £50,750 ($62,848.30).

Anpario Stock Performance

LON:ANP opened at GBX 224 ($2.77) on Wednesday. The firm’s fifty day moving average price is GBX 295.62 and its 200 day moving average price is GBX 382.08. Anpario plc has a 1-year low of GBX 177.70 ($2.20) and a 1-year high of GBX 611.50 ($7.57). The company has a debt-to-equity ratio of 0.13, a current ratio of 6.71 and a quick ratio of 5.16. The firm has a market cap of £53.78 million, a price-to-earnings ratio of 1,493.33 and a beta of 0.73.

Anpario Increases Dividend

The company also recently disclosed a dividend, which will be paid on Friday, July 28th. Investors of record on Thursday, July 13th will be given a GBX 7.35 ($0.09) dividend. This represents a yield of 2.37%. This is a positive change from Anpario’s previous dividend of $3.15. The ex-dividend date is Thursday, July 13th. Anpario’s dividend payout ratio (DPR) is 6,666.67%.

Analyst Upgrades and Downgrades

Separately, Shore Capital reaffirmed a “buy” rating on shares of Anpario in a report on Thursday, March 30th.

Anpario Company Profile

(Get Rating)

Anpario plc, together with its subsidiaries, produces and distributes natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salgard, Salkil, Genex, and Optimax brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Salkil, Salgard, Oxigard, Moldgard, and Mastercube brands.

See Also

Receive News & Ratings for Anpario Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anpario and related companies with MarketBeat.com's FREE daily email newsletter.